Search
forResearch 10 of 1000+
- Hair follicles, their disorders and their opportunities
- A9. Excess hair: physical and pharmacological treatments
- Methods for quantifying intrafollicular drug delivery: a critical appraisal
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
- Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- Anti-anginal and beta-adrenoceptor blocking drugs
- Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →